Skip to main content
# Title Department Research Year
141 Insights into the lipophilicity of four commonly prescribed antidiabetic drugs and their simultaneous analysis using a simple TLC-spectrodensitometric method: Application to fixed-dose combination tablets and human plasma Department of Pharmaceutical Analytical Chemistry 2022
142 In vivo investigation of the potential hypoglycemic activity of Pennisetum setaceum: Justification of the traditional use among Jordanians 2022
143 Design and synthesis of new triarylimidazole derivatives as dual inhibitors of BRAFV600E/p38α with potential antiproliferative activity Department of Pharmaceutical Organic Chemistry 2022
144 The inhibitory coreceptor CD22 restores B cell signaling by developmentally regulating Cd45 −/− immunodeficient B cells Department of Pharmaceutical Organic Chemistry 2022
145 Synthesis of novel amidines via one-pot three component reactions: Selective topoisomerase I inhibitors with antiproliferative properties 2022
146 Clinical translation of nanomedicines: Challenges, opportunities, and keys Department of Industrial Pharmacy 2022
147 Exploration of components contributing to potent cytotoxicity of Gardenia thunbergia L. f. against human leukemia and hepatoma Department of Pharmacognosy 2022
148 Design and optimization of PEGylated silver nanoparticles for efficient delivery of Doxorubicin to cancer cells Department of Industrial Pharmacy 2022
149 Evaluation of Different Surface Coating Agents for Selenium Nanoparticles: Enhanced Anti-Inflammatory Activity and Drug Loading Capacity Department of Pharmaceutics 2022
150 Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis Department of Pharmaceutical Organic Chemistry 2022